Kelly J. Lundberg
No Rating Available
(Learn About Our Rating System)

Kelly J. Lundberg, PhD

Languages spoken: English

  • Kelly is a licensed psychologist who is an Associate Professor and Director of Operations in the Department of Psychiatry at the University of Utah. Dr. Lundberg was the recipient of the Governor’s Award for Contributions to Substance Abuse Treatment and Anti-Violence in 1997 and was the 2006 recipient of the Treatment Award from the State Division of Substance Abuse and Mental Health. She has a statewide reputation as one of the leading experts in addictions and is sought throughout Utah for her teaching and consultative services.

    Specialties

  • Kelly is a licensed psychologist who is an Associate Professor and Director of Operations in the Department of Psychiatry at the University of Utah. Dr. Lundberg was the recipient of the Governor’s Award for Contributions to Substance Abuse Treatment and Anti-Violence in 1997 and was the 2006 recipient of the Treatment Award from the State Division of Substance Abuse and Mental Health. She has a statewide reputation as one of the leading experts in addictions and is sought throughout Utah for her teaching and consultative services.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Primary
    Academic Divisions Adult Psychiatry

    Education history

    Internship Psychology - Veterans Affairs Medical Center Intern
    Counseling Psychology - University of Iowa Ph.D.
    Graduate Training Clinical Psychology - Indiana University of Pennsylvania Master's
    Psychology - Northern Michigan University B.S.

    Selected Publications

    Journal Article

    1. Fritz JM, Del Fiol G, Gibson B, Wetter DW, Solis V, Bennett E, Thackeray A, Goode A, Lundberg K, Romero A, Ford I, Stevens L, Siaperas T, Morales J, Yack M, Greene T (2022). BeatPain Utah: study protocol for a pragmatic randomised trial examining telehealth strategies to provide non-pharmacologic pain care for persons with chronic low back pain receiving care in federally qualified health centers. BMJ Open, 12(11), e067732. (Read full article)
    2. Gibson B, Simonsen S, Barton J, Zhang Y, Altizer R, Lundberg K, Wetter DW (2021). Motivation and Problem Solving Versus Mobile 360° Videos to Promote Enrollment in the National Diabetes Prevention Program's Lifestyle Change Program Among People With Prediabetes: Protocol for a Randomized Trial. JMIR Res Protoc, 10(6), e28884. (Read full article)
    3. Ulrich CM, Himbert C, Boucher K, Wetter DW, Hess R, Kim J, Lundberg K, Ligibel JA, Barnes CA, Rushton B, Marcus R, Finlayson SRG, LaStayo PC, Varghese TK (2018). Precision-Exercise-Prescription in patients with lung cancer undergoing surgery: rationale and design of the PEP study trial. BMJ Open, 8(12), e024672. (Read full article)
    4. Hellem TL, Sung YH, Shi XF, Pett MA, Latendresse G, Morgan J, Huber RS, Kuykendall D, Lundberg KJ, Renshaw PF (2015). Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study. J Dual Diagn, 11(3-4), 189-202. (Read full article)
    5. Sung YH, Yurgelun-Todd DA, Kondo DG, Shi XF, Lundberg KJ, Hellem TL, Huber RS, McGlade EC, Jeong EK, Renshaw PF (2015). Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects. Am J Drug Alcohol Abuse, 41(4), 281-9. (Read full article)
    6. Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, Huber RS, Fiedler KK, Harrell RE, Nickerson BR, Kim SE, Jeong EK, Renshaw PF (2013). Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug Alcohol Depend, 129(1-2), 102-9. (Read full article)
    7. Ravarino JM, Gardner MK, Hill RD, Lundberg K (2008). Effectiveness of pretreatment interim support group attendance in facilitating treatment enrollment among methamphetamine abusers. Addict Behav, 33(2), 336-41. (Read full article)
    8. Burrow-Sanchez JJ, Lundberg KJ (2007). Readiness to change in adults waiting for publicly funded substance abuse treatment. Addict Behav, 32(1), 199-204. (Read full article)

    Review

    1. Hellem TL, Lundberg KJ, Renshaw PF (2015). A review of treatment options for co-occurring methamphetamine use disorders and depression. [Review]. J Addict Nurs, 26(1), 14-23; quiz E1. (Read full article)